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Cardiovascular pathology leads to the death in the ma-
jority cases both in adults and children with chronic kidney 
disease (CKD) [1, 2]. However, in children and adole scents 
with CKD, cardiovascular complications usually have 
subclinical course, starting developing already at the early 
stages [3, 4]. With the progression of CKD, the importance 
of the sympathetic nervous system increases, which activity 
is accompanied by the increase of cardiovascular risks [5]. 
Damage and disorder of the structures of the autonomic 
nervous system leads to morphological rearrangements of 
the cardiovascular system associated with the release of me-
diators, hormones, biologically active substances, which, in 
turn, enhance the autonomic imbalance and provoke the 
development of a number of biochemical and immune 
shifts in the body [6]. At present, the most informative 
non-invasive method for quantitative assessment of the au-
tonomic regulation of heart rate is the study of heart rate 
variability (HRV), which gives an opportunity to get an idea 
of  the functional state of the CNS and to identify changes 
in vegetative homeostasis in children. In scientific publica-
tions, information on the results of HRV study in adult pa-
tients with terminal stage of chronic renal failure [7–9], as 
well as the effect of hemodialysis on the parameters of the 
CNS in this cohort of patients [10, 11] were highlighted. 
There are no enough data on the state of functional reserves 
of autonomic regulation, neurohumoral regulation of the 
heart, the ratio between sympathetic and parasympathe-
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Abstract. Background. Assessment of heart rate variability allows us to get an idea about the functional 
state of the autonomic nervous system and to identify changes in autonomic homeostasis in children. The 
purpose was to study the features of vegetative regulation in children with chronic pyelonephritis at the ini-
tial stages of chronic kidney disease by analyzing heart rate variability. Materials and methods. There were 
surveyed 94 children aged 6–17 years without exacerbation of chronic pyelonephritis with CKD stage I–III. 
There was conducted daily monitoring of ECG, followed by mathematical processing. Results. Analysis of 
the statistical characteristics of the Z-scores of the time analysis indicators revealed a significant decrease 
in the standard (root-mean-square) deviations of the RR interval in patients of all groups with a significant 
decrease in this indicator in children with CKD stage III. A significant decrease in RMSSD values was demon-
strated in patients with CKD stage III, and patients with CKD stages I to III demonstrated pNN50 decline. In 
a spectral analysis, patients showed a significant increase in the total power of the spectrum of heart rate 
variability of TP and its domains (VLF, LF), sympathetic-parasympathetic ratio of LF to HF and decrease of 
HF. Conclusions. 76.6 % of children with chronic pyelonephritis and CKD stage I–III presented with the ve-
getative imbalance. With the progression of CKD, the autonomic imbalance exacerbated, as evidenced 
by the presence of correlations between the glomerular filtration rate and findings of time (SDNN, pNN50) 
and spectral (TP, LF, HF) analysis of heart rate variability. The revealed changes suggest the expected de-
velopment of cardiovascular disorders even before the appearance of significant changes in the central 
hemodynamics.
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tic parts of the autonomic nervous system in children with 
CKD [12, 13].
Purpose: to study the peculiarities of autonomic regu-
lation in children with chronic pyelonephritis at the initial 
stages of CKD by analyzing the heart rate variability.
Materials and methods
There were examined 94 children aged from 6 to 17 years 
(41 boys and 53 girls) with chronic pyelonephritis with CKD 
stage I–III. The control group consisted of 78 virtually 
healthy children of the corresponding age. The patients were 
divided into groups depending on the stage of chronic kid-
ney disease: the first group included 47 children with CKD 
stage I (GFR > 90 ml/min), the second group — 30 patients 
with CKD stage II (GFR from 60 to 90 ml/min), the third 
group — 17 patients with CKD stage III (GFR from 30 to 
59 ml/min).
The planned clinical trial was approved by the Bio ethics 
Committee of Dnipropetrovsk Medical Academy of the 
Ministry of Health of Ukraine and conducted in accordance 
with the guidelines of the Helsinki Declaration (1975). All 
participants and/or their parents were fully informed about 
the methods and scope of the study and provided written in-
formed consent to participate.
The criteria for inclusion of patients in the study were 
following: the presence of the voluntary informed consent 
of a child and his/her parents to participate in the clinical 
study; age of patients from 6 years to 17 years 11 months 29 
days; presence of verified diagnosis of chronic pyelonephri-
tis; the absence of clinical and laboratory signs of exacerba-
tion of chronic pyelonephritis. The criteria for exclusion of 
patients from the study were: refusal of a child or his/her 
parents to participate in a clinical trial; the presence of con-
genital heart disease or other primary cardiac diseases, acute 
infections.
All patients and children of the control group under-
went daily ECG monitoring using the software-hardware 
complex Cardiotechnika-04-AD-1 (Inkart, St. Petersburg, 
Russia). The dynamic series of cardiac intervals detected 
du ring cardiointervalographic study were processed using 
the mathematical analysis of HRV. The HRV assessment 
was conducted in time and spectral analysis regimes in ac-
cordance with the International Standards of Measurement, 
Physiological Interpretation and Clinical Use developed by 
the European Society of Cardiology and North American 
Society of Pacing and Electrophysiology.
For time analysis of HRV, the following parameters were 
used: SDNN (ms) — standard (square root) RR deviation, 
SDNN index (ms) — average 5 minute standard deviation 
throughout the recording, SDANN (ms) — RMS deviation 
calculated on the basis of RR intervals, which were ave raged 
over every 5 minutes of the recording, RMSSD (ms) — 
mean square deviation of inter-interval differences (acti-
vity of parasympathetic influences), pNN50 (%) — share 
of adjacent RR intervals, inter-interval differences between 
which exceed 50 ms of spectral power (ms2). The decrease 
in the values of time parameters of heart rate variability was 
interpreted as an enhancement of sympathetic effects, the 
increase — as the activation of parasympathetic ones.
Spectral analysis was carried out by means of a fast Fou-
rier transform with the calculation of the total power of the 
spectrum — TP (ms2) and its three components in the fol-
lowing frequency band: very low frequencies (VLF) (0.003–
0.04 Hz), which characterizes the degree of connection of 
autonomous segmentary levels of blood circulation regula-
tion with suprasegmentary; the power of the low frequency 
(LF) spectrum (0.04–0.15 Hz), which mainly reflects the 
activity of the sympathetic part of the autonomic nervous 
system; the power of the high frequency (HF) spectrum 
(0.15–0.4 Hz), which characterizes the influence of the 
parasympathetic part; as well as the sympatho-parasympa-
thetic index of the LF/HF — the index reflecting the ba-
lance of the sympathetic and parasympathetic parts.
The results were statistically processed using the Statis-
tica 8.0 program. The verification of the distribution accor-
ding to the Gauss’s law was carried out using the Shapiro-
Wilk test. Given that most of the samples did not conform to 
the Gauss’s law, the results were presented as median (Me) 
and interquartile range (Q25; Q75). Due to the age and gen-
der dependence of heart rate variability in children, Z-esti-
mates were used in order to compare with the corresponding 
normative parameters. The Z-estimate was the degree of de-
viation from the arithmetic mean of the statutory indicator 
for this age group expressed in terms of the standard devia-
tion of the same series, or by the formula: Z = (X – Хn) / 
Sx, where X — the value of the obtained indicator in the exa-
mined child, Xn — the arithmetic mean of the normative 
indicator in this age group, S — the standard deviation of the 
arithmetic mean of the statutory indicator. Mann-Whitney 
criterion was used to compare the groups. A correlation and 
one-factor dispersion analysis was performed to determine 
the relationship between the indicators. The difference be-
tween values  was considered statistically verisimilar at the 
level of significance criterion — p < 0.05.
Results
In children with chronic pyelonephritis and CKD stage 
I–III, when compared with statutory indicators, the uni-
directional nature of changes in the time indices (SDNN, 
RMSSD, pNN50) (Table 1) and spectral analysis (TP, LF, 
HF, LF/HF) of HRV was recorded (Table 2).
Analysis of the statistical characteristics of Z-estimates 
of time analysis indicators revealed a probable decrease in 
SDNN levels in patients in all groups with the most signifi-
cant decrease in this indicator in children with CKD stage 
III. A sharp decline in SDNN (greater than 3 S) was ob-
served in 4.26 % of patients with CKD stage I, 13.3 % of 
patients with CKD stage II and in 35.3 % of patients with 
CKD stage III. The levels of RMSSD and pNN50, which 
are indicators of activity of the parasympathetic chain of 
vegetative regulation, also tended to decrease. However, the 
probable decrease in comparison with the control group was 
demonstrated for RMSSD in patients with CKD stage III, 
and for pNN50 — in patients with CKD stage I and III.
Describing the general tendencies of changes in the pa-
rameters of the spectral analysis of HRV, it can be noted that 
for patients with CKD stages І–ІІІ as compared with the 
control group, there is a verisimilar gradual increase in the 
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total power of HRV spectrum and its domain LF. At the same 
time, with the progression of CKD, a pro bable decrease in 
the power of the high-frequency spectrum was recorded. 
The degree of changes in the power of HRV spectrum had 
probable group differences both for the low-frequency com-
ponent (H = 23.22; p = 0.0001) and for high-frequency 
component (H = 14.45; p = 0.0023).
A significant decrease in the power of the high-frequen-
cy component against the background of low-frequency le-
vels has led to a statistically significant increase in the ratio 
of LF/HF in patients with CKD stages І–ІІІ, as compared 
to healthy subjects, without any intergroup differences 
(H = 1.67; p = 0.8725).
Additionally, Spearman correlation analysis revealed 
likely correlations between the levels of glomerular filtra-
tion rate and HRV indices, namely, GFR and SDNN 
(r = +0.564; p = 0.023), GFR and pNN50 (r = +0.492; 
p = 0.037), GFR and TP, LF, HF (r = –0.591, p = 0.030; 
r = –0.662, p = 0.012; r = +0.627, p = 0.018, respectively).
Discussion
In our study in children with chronic pyelonephritis and 
CKD stages I–III, reliable shifts in both total HRV and 
domains were determined, which according to the present 
data is a complication of CKD, and not the initial state [14]. 
Probable changes in the SDNN, TP, LF and HF indices in 
the examined patients during the day reflect the decrease 
in the total effect of autonomous blood circulation regula-
tion, associated with the increase of sympathetic regulation, 
which inhibits the activity of the autonomous circuit. The 
indicated signs of autonomous dysregulation are intensi-
fied by the presence of a possible decrease in the parameters 
characterizing the activity of the parasympathetic chain 
of vegetative regulation, namely: RMSSD in patients with 
GFR below 60 ml/min and pNN50 in all groups of patients 
with CKD. Reduced power of the high frequency compo-
nent resulted in a statistically significant increase in LF/HF 
ratio in children with CKD in all groups as compared with 
healthy subjects without group differences. The increase 
in this indicator is also a reflection of vegetative imbalance 
toward hypersympathicotonia. The indicated shifts in the 
regulation of the autonomous circuit have been confirmed 
by the studies performed both among the adult contingent 
[15] and in the pediatric population [12, 16].
The power of the very low-frequency component of 
HRV spectrum of VLF characterizes the activity of the 
sympathetic part of the autonomic nervous system [17, 
18]. However, in this case we are talking about more com-
plex influences of the supra-segmentary level of regulation, 
since the amplitude of this domain is closely related to the 
Table 1. Z-estimate of time characteristics of heart rate variability in children with chronic pyelonephritis  
and chronic kidney disease, Me (Lq; Uq)
Indicators
Groups of examined patients
р
1st (n = 47) 2nd (n = 30) 3rd (n = 17)
SDNN, ms
24 hours –1.37* (–2.08; –0.68) –1.42* (–2.36; –0.94) –2.68* (–3.24; –1.62)
р1–2 = 0.4121 
р1–3 = 0.0232 
р2–3 = 0.062
Day –1.43* (–2.15; –0.77) –1.45* (–2.43; –0.97) –2.78* (–3.24; –1.62)
р1–2 = 0.4651 
р1–3 = 0.0273 
р2–3 = 0.057
Night –1.22 (–1.78; –0.62) –1.39* (–2.29; –0.92) –2.44* (–2.86; –1.43)
р1–2 = 0.5465 




24 hours –0.97 (–1.54; –0.65) –0.49 (–1.07; –0.48) –1.40* (–1.76; –0.95)
р1–2 = 0.0355 
р1–3 = 0.3791 
р2–3 = 0.0371
Day –0.69 (–1.27; –0.49) –0.42 (–0.92; –0.37) –1.22* (–1.56; –0.88)
р1–2 = 0.0365 
р1–3 = 0.4564 
р2–3 = 0.0291
Night –1.09 (–1.69; –0.77) –0.57 (–1.23; –0.55) –1.49* (–1.77; –0.98)
р1–2 = 0.0321 
р1–3 = 0.4427 
р2–3 = 0.0251
pNN50, %
24 hours –2.80* (–3.66; –1.14) –0.99 (–3.54; 0.11) –3.50* (–3.72; –2.63)
р1–2 = 0.0730 
р1–3 = 0.4123 
р2–3 = 0.0348
Day –2.78* (–3.56; –1.11) –0.69 (–3.44; 0.56) –3.45* (–3.65; –2.68)
р1–2 = 0.0643 
р1–3 = 0.2734 
р2–3 = 0.0345
Night –2.84* (–3.73; –1.17) –1.63* (–3.62; –0.41) –3.54* (–3.76; –2.59)
р1–2 = 0.0881 
р1–3 = 0.4536 
р2–3 = 0.0443
Note: * — statistically significant difference with the indicators of the control group.
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psycho-emotional stress and functional state of the cerebral 
cortex, and the power of VLF fluctuations is a sensitive in-
dicator of metabolic process control. That is, VLF reflects 
the effect of higher autonomic centers on the cardiovascular 
subcortical center, the state of neurohumoral and metabolic 
regulation levels and can be used as a marker for the rela-
tionship between the segmentary levels of blood flow regula-
tion with supra-segmentary ones [19–21]. The increase in 
the level of VLF, which indicates high power compensatory 
mechanisms and can lead to disruption of the adaptive re-
serves of the organism was recorded in 21.3 % of patients 
with CKD stage I, in 20.0 % of children with CKD stage II 
and in 11.8 % of patients with CKD stage III. Reduction in 
the power of the VLF spectrum, which confirms the deple-
tion of the energy reserves of the body, was recorded at night 
and was typical for 61.7 % of patients with CKD stage I, 
Table 2. Z-estimate of spectral characteristics of heart rate variability in children with chronic pyelonephritis  
and chronic kidney disease, Me (Lq; Uq)
Indicators
Groups of examined patients
р
1st (n = 47) 2nd (n = 30) 3rd (n = 17)
TP, ms2
24 hours 0.89 (–0.67; 1.47) 1.45 (0.22; 1.65) 3.46* (1.53; 5.07)
р1–2 = 0.3426 
р1–3 = 0.0478 
р2–3 = 0.0345
Day 0.92 (–0.19; 1.65) 1.42 (–0.14; 2.09) 4.87* (2.72; 6.03)
р1–2 = 0.5126 
р1–3 = 0.0212 
р2–3 = 0.0127
Night –0.11 (–0.31; 1.45) 1.22 (–0.25; 2.31) 7.56* (2.25; 11.29)
р1–2 = 0.3159 
р1–3 = 0.0006 
р2–3 = 0.0031
VLF, ms2
24 hours 3.34* (2.37; 3.72) 2.77* (0.47; 4.27) 4.14* (2.61; 4.99)
р1–2 = 0.0886 
р1–3 = 0.0743 
р2–3 = 0.0498
Day 3.98* (2.59; 4.56) 2.93* (0.88; 3.87) 4.54* (2.55; 4.86)
р1–2 = 0.0182 
р1–3 = 0.0053 
р2–3 = 0.0533
Night 0.59 (0.26; 1.27) 2.61* (0.30; 3.54) 3.89* (2.02; 4.56)
р1–2 = 0.0617 
р1–3 = 0.5927 
р2–3 = 0.0087
LF, ms2
24 hours 2.55* (1.79; 2.79) 1.91* (1.33; 3.51) 5.11* (3.67; 7.94)
р1–2 = 0.0794 
р1–3 = 0.0019 
р2–3 = 0.0000
Day 1.88* (1.76; 2.41) 1.69* (1.43; 2.47) 6.46* (3.32; 7.29)
р1–2 = 0.3311 
р1–3 = 0.0012 
р2–3 = 0.0000
Night 1.46 (–0.65; 1.59) 2.86* (1.77; 3.35) 4.21* (3.23; 6.17)
р1–2 = 0.0145 
р1–3 = 0.0009 
р2–3 = 0.0002
HF, ms2
24 hours –0.60 (–1.21; –0.46) –3.20* (–9.61; 0.68) –12.72* (–14.41; –9.05)
р1–2 = 0.0365 
р1–3 = 0.0241 
р2–3 = 0.0025
Day –9.64* (–10.98; –6.12) –6.36* (–9.46; 0.47) –12.69* (–13.79; –9.12)
р1–2 = 0.0312 
р1–3 = 0.0160 
р2–3 = 0.0015
Night 1.23 (–1.21; 1.25) –6.12* (–9.61; 0.55) –12.81* (–14.56; –9.18)
р1–2 = 0.0312 
р1–3 = 0.0160 
р2–3 = 0.0015
LF/HF
24 hours 1.34 (–0.7; 3.53) 1.80* (–0.47; 5.12) 2.62* (0.7; 10.10)
р1–2 = 0.3625 
р1–3 = 0.0042 
р2–3 = 0.0635
Day 3.37* (2.01; 5.47) 1.86* (–0.45; 4.92) 2.66* (0.88; 10.16)
р1–2 = 0.4133 
р1–3 = 0.8332 
р2–3 = 0.2345
Night 1.21 (0.85; 2.76) 1.69* (–0.50; 5.23) 2.60* (0.66; 9.97)
р1–2 = 0.3112 
р1–3 = 0.0720 
р2–3 = 0.3052
Note: * — statistically significant difference with the indicators of the control group.
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70.0 % of patients with CKD stage II, and 76.5 % of chil-
dren with CKD stage III.
The results of our study suggest that in children with 
chronic pyelonephritis changes in total HRV occur gradu-
ally during CKD progression, rather in the decrease of renal 
function, which is confirmed by the presence of probable 
correlations between GFR and the main indicators of HRV. 
This assumption is also evidenced in studies conducted 
among adult patients with CKD of IV–V stages [15, 22], and 
in a cohort of pediatric patients [12, 16]. At the same time, it 
was found that by the levels of most indicators of both time 
and spectral analysis of HRV, there is no probable difference 
between patients with CKD stage І and ІІ. This is likely to 
be due to the fact that the overwhelming majority of patients 
with GFR below 90 ml/min received angiotensin conver-
ting enzyme inhibitors as a component of renonoprotective 
therapy for a long time, which, accor ding to modern ideas, 
contribute to the normalization of total HRV [23–25].
Conclusions
1. In 76.6 % of children with chronic pyelonephritis 
and CKD of I–III stages, vegetative imbalance is detected, 
which manifests in HRV (growth of TP, LF, LF/HF and 
reduced SDNN, RMSSD, pNN50, HF). These changes 
reflect the shift of vago-sympathetic balance toward weake-
ning of the parasympathetic and domination of the tone of 
the sympathetic part of the nervous system.
2. Gradual loss of renal functions, which occurs du-
ring CKD progression, exacerbates autonomic imbalance, 
which is confirmed by the presence of probable correla-
tions between the integral index of renal function (GFR) 
and findings of time (SDNN, pNN50) and spectral (TP, LF, 
HF) analysis of HRV.
3. The autonomic imbalance with the weakening of the 
parasympathetic and domination of the sympathetic tone 
of the nervous system obviously leads to the weakening of 
the overall adaptive capacities of the organism and demon-
strates expected development of cardiovascular disorders 
even before the appearance of significant changes of central 
hemodynamics.
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Варіабельність серцевого ритму в дітей із хронічним пієлонефритом і хронічною хворобою нирок I–III стадії
Резюме. Актуальність. Оцінка варіабельності серцевого 
ритму дає можливість отримати уявлення щодо функціональ-
ного стану вегетативної нервової системи та ідентифікувати 
зміни вегетативного гомеостазу в дітей. Мета роботи: ви-
вчити особливості вегетативної регуляції в дітей із хронічним 
пієлонефритом на початкових стадіях хронічної хвороби ни-
рок (ХХН) шляхом аналізу варіабельності серцевого ритму. 
Матеріали та методи. Обстежено 94 дитини віком від 6 до 
17 років поза загостренням хронічного пієлонефриту з ХХН 
I–III стадії. Проводилось добове моніторування електрокар-
діограми з подальшою математичною обробкою. Результати. 
Аналіз статистичних характеристик Z-оцінок показників ча-
сового аналізу виявив вірогідне зниження значень стандарт-
ного (середньоквадратичного) відхилення інтервалу RR у 
хворих усіх груп із суттєвим зменшенням цього показника в 
дітей із ХХН ІІІ стадії. Вірогідне зменшення показника ак-
тивності парасимпатичних впливів RMSSD продемонстру-
вали хворі з ХХН ІІІ стадії, а показника pNN50 — пацієнти 
з І та ІІІ стадією ХХН. При спектральному аналізі у хворих 
виявлено вірогідне збільшення загальної потужності спек-
тра варіабельності серцевого ритму (ТР) і його доменів (VLF, 
LF), симпато-парасимпатичного співвідношення LF/HF та 
зниження потужності високочастотного спектра (HF). Ви-
сновки. У 76,6 % дітей із хронічним пієлонефритом та ХХН 
І–ІІІ стадії відзначається порушення вегетативного балансу. 
Із прогресуванням ХХН вегетативний дисбаланс поглиблю-
ється, що підтверджується наявністю вірогідних кореляцій 
між швидкістю клубочкової фільтрації та показниками ча-
сового (SDNN, pNN50) і спектрального (TP, LF, HF) аналізу 
варіабельності серцевого ритму. Виявлені зміни свідчать про 
очікуване формування кардіоваскулярних порушень ще до 
появи значущих змін центральної гемодинаміки.
Ключові слова: варіабельність серцевого ритму; діти; хро-
нічний пієлонефрит; хронічна хвороба нирок
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Вариабельность сердечного ритма у детей с хроническим пиелонефритом  
и хронической болезнью почек I–III стадии
Резюме. Актуальность. Оценка вариабельности сердечного 
ритма дает возможность получить представление о функцио-
нальном состоянии вегетативной нервной системы и иден-
тифицировать изменения вегетативного гомеостаза у детей. 
Цель работы: изучить особенности вегетативной регуляции 
у детей с хроническим пиелонефритом на начальных стадиях 
хронической болезни почек (ХБП) путем анализа вариабель-
ности сердечного ритма. Материалы и методы. Обследовано 
94 ребенка в возрасте от 6 до 17 лет вне обострения хрониче-
ского пиелонефрита с ХБП I–III стадии. Проводилось суточ-
ное мониторирование электрокардиограммы с последующей 
математической обработкой. Результаты. Анализ статисти-
ческих характеристик Z-оценок показателей временного 
анализа выявил достоверное снижение значений стандарт-
ного (среднеквадратического) отклонения интервала RR у 
больных всех групп с существенным уменьшением этого по-
казателя у детей с ХБП III стадии. Достоверное уменьшение 
показателя RMSSD продемонстрировали больные с ХБП III 
стадии, а показателя pNN50 — пациенты с I и III стадией 
ХБП. При спектральном анализе у больных выявлено досто-
верное увеличение общей мощности спектра вариабельности 
сердечного ритма (ТР) и его доменов (VLF, LF), симпато-па-
расимпатического соотношения LF/HF и снижение мощно-
сти высокочастотного спектра (HF). Выводы. У 76,6 % детей 
с хроническим пиелонефритом и ХБП I–III стадии отмеча-
ется нарушение вегетативного баланса. С прогрессированием 
ХБП вегетативный дисбаланс усугубляется, что подтвержда-
ется наличием корреляций между скоростью клубочковой 
фильтрации и показателями временного (SDNN, pNN50) 
и спектрального (TP, LF, HF) анализа вариабельности сер-
дечного ритма. Выявленные изменения свидетельствуют об 
ожидаемом формировании кардиоваскулярных нарушений 
еще до появления значимых изменений центральной гемо-
динамики.
Ключевые слова: вариабельность сердечного ритма; дети; 
хронический пиелонефрит; хроническая болезнь почек
